DUBLIN–(BUSINESS WIRE)–The “Point of Care (POC) Analyzers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update” report has been added to ResearchAndMarkets.com’s offering.
The report provides comprehensive information about the Point of Care (POC) Analyzers pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Scope
- Extensive coverage of the Point of Care (POC) Analyzers under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Point of Care (POC) Analyzers and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment/industry
Reasons to Buy
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Point of Care (POC) Analyzers under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Key Topics Covered:
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Point of Care (POC) Analyzers Overview
3 Products under Development
3.1 Point of Care (POC) Analyzers – Pipeline Products by Stage of Development
3.2 Point of Care (POC) Analyzers – Pipeline Products by Segment
3.3 Point of Care (POC) Analyzers – Pipeline Products by Territory
3.4 Point of Care (POC) Analyzers – Pipeline Products by Regulatory Path
3.5 Point of Care (POC) Analyzers – Pipeline Products by Estimated Approval Date
3.6 Point of Care (POC) Analyzers – Ongoing Clinical Trials
4 Point of Care (POC) Analyzers – Pipeline Products under Development by Companies
4.1 Point of Care (POC) Analyzers Companies – Pipeline Products by Stage of Development
4.2 Point of Care (POC) Analyzers – Pipeline Products by Stage of Development
5 Point of Care (POC) Analyzers Companies and Product Overview
6 Point of Care (POC) Analyzers- Recent Developments
6.1 Aug 22, 2022: Co-Diagnostics to Present at 14th Next Generation Dx Summit in Washington, D.C.
6.2 Aug 11, 2022: Co-Diagnostics Reports Second Quarter 2022 Financial Results
6.3 Aug 03, 2022: McKesson Corp Reports Fiscal 2023 First-Quarter Results
6.4 Jun 29, 2022: McKesson Corp Announces First Quarter Fiscal 2023 Earnings Release Date
6.5 Jun 15, 2022: Co-Diagnostics to Present at Sidoti Summer Small Cap Virtual Conference
6.6 May 19, 2022: Co-Diagnostics to Participate in the H.C. Wainwright 2022 Global Investment Conference on May 23-26
6.7 Apr 28, 2022: Co-Diagnostics Announces First Quarter 2022 Earnings Release Date and Webcast
6.8 Apr 07, 2022: McKesson Corporation Completes Divestiture of UK Businesses, Announces Fourth Quarter Fiscal 2022 Earnings Release Date
6.9 Apr 01, 2022: McKesson’s Board of Directors Elects W. Roy Dunbar as New Director
6.10 Mar 17, 2022: Co-Diagnostics Makes Strategic Additions to Scientific Advisory Board
6.11 Mar 14, 2022: Co-diagnostics Announces Fourth Quarter and Full Year 2021 Earnings Release Date and Webcast
6.12 Feb 07, 2022: Ontada Names Dr. Nicholas Robert as Chief Medical Officer
6.13 Jan 25, 2022: Ontada Names Viraj Narayanan as Chief Commercial Officer
6.14 Jan 18, 2022: McKesson’s Board of Directors Elects James H. Hinton and Kathleen Wilson-Thompson as New Directors
6.15 Jan 10, 2022: Co-Diagnostics to Participate in the HC Wainwright 2022 BioConnect Virtual Conference on January 10-13
6.16 Dec 08, 2021: McKesson Investor Day to Highlight Progress Against Growth Strategies and Long-Term Financial Targets
6.17 Sep 20, 2021: Co-Diagnostics to Present at Sidoti Virtual Investor Conference
7 Appendix
Companies Mentioned
- Access Bio Inc
- Acousort AB
- Acrongenomics Inc (Inactive)
- AgPlus Diagnostics LTD
- Akonni Biosystems Inc
- Alere Inc
- All Medicus Co Ltd
- Analytical Diagnostic Solutions Inc
- ApoCell Inc
- Aptatek BioSciences Inc
- AquaBioChip, LLC
- Arogyam Medisoft Solution Pvt Ltd
- Atonomics A/S (Inactive)
- Aviv Biomedical, Inc.
- Besst Test
- Binghamton University
- Bio-AMD Inc
- BioMedomics Inc
- Biopico Systems Inc
- Biosensia Ltd
- Boston University
- BreviTest Technologies LLC
- Brigham and Women’s Hospital
- Canon USA Inc
- CardioGenics Inc
- Center for Innovation in Point-of-Care Technologies for HIV/AIDS
- ChipCare Corp
- Chrogene Aarogyam Biotech Pvt Ltd
- Chronus Health Inc
- City, University of London
- Co-Diagnostics Inc
- Cornell University
- Curetis GmbH
- Duke University
- Edan Instruments Inc
- EKF Diagnostics Holdings Plc
- Electrocyt, Inc.
- Emergent Detection Inc (Inactive)
- Endeavor Sciences Inc
- Entegrion Inc
- ExcitePCR Corp
- Fable Biyoteknoloji San ve Tic AS
- Fawkes Biotechnology LLC
- First Light Diagnostics Inc
- Florida International University
- Future Diagnostics Solutions BV
- Giner Inc
- GlucoSentient Inc
- Glyconics Ltd
- Haemokinesis Pty Ltd
- HemoPalm Corp
- IdbyDNA Inc
- Indian Institute of Science
- Intelligent Optical Systems, Inc.
- Invivomon Inc (Inactive)
- I-Sens Inc
- LabNow Inc (Inactive)
- LightDeck Diagnostics Inc
- Louisiana State University
- Lucendi Inc
- Masaryk University
- Maxygen-mobile DNA tests
- McKesson Corp
- Memorial Sloan Kettering Cancer Center
- MicroTech Medical Co Ltd
- MML Ltd
- MobioSense Inc
- MyMD Pharmaceuticals, Inc
- Nalia Systems Ltd
- Nanomix Inc
- Newcastle University
- Nikkiso Co Ltd
- Nova Biomedical Corp
- Novel Microdevices LLC
- Ohmx Corp
- OncoGenesis
- Ontera Inc
- Optolane Technologies Inc
- Oregon State University
- Pacific Nanoscience, Inc.
- POC Medical Systems Inc
- ProciseDx LLC
- Prominex Inc
- Quanterix Corp
- Qvella Corp
- Radisens Diagnostics Ltd
- Rapid Diagnostic Pvt Ltd
- RMIT University
- Scryb Inc
- SeLux Diagnostics Inc
- SenGenix Inc
- SepTec
- Smiths Detection Inc
- StemTek Therapeutics SL
- Sugentech Inc
- The Hong Kong University of Science and Technology
- Thermal Gradient Inc
- ThreeFold Sensors (Inactive)
- Trinity Biotech Plc
- University of Calgary
- University of California Berkeley
- University of Glasgow
- University of Illinois at Urbana-Champaign
- University of Pittsburgh
- Ural Federal University
- ViroGates AS
- Wellstat Diagnostics LLC
For more information about this report visit https://www.researchandmarkets.com/r/l9ui5j
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
